Literature DB >> 25491284

Phosphorus-nitrogen compounds: part 30. Syntheses and structural investigations, antimicrobial and cytotoxic activities and DNA interactions of vanillinato-substituted NN or NO spirocyclic monoferrocenyl cyclotriphosphazenes.

Yasemin Tümer1, L Yasemin Koç, Nuran Asmafiliz, Zeynel Kılıç, Tuncer Hökelek, Hossien Soltanzade, Leyla Açık, Mehmet Lütfi Yola, Ali Osman Solak.   

Abstract

The gradual Cl replacement reactions of NN (1-3) or NO spirocyclic monoferrocenyl cyclotriphosphazenes (4 and 5) with the potassium salt of 4-hydroxy-3-methoxybenzaldehyde (potassium vanillinate) resulted in the mono (1a-5a), geminal (gem-1b-5b), non-geminal (cis-5b and trans -1b-4b), tri (1c, 3c-5c) and tetra-vanillinato-substituted phosphazenes (1d-5d). All the phosphazene derivatives have stereogenic P-center(s), except tetra-substituted ones. The vanillinatophosphazenes have reversible voltammograms with one-electron anodic and cathodic peaks which are attributed to ferrocenyl redox probe. The structures of the new phosphazene compounds were determined by FTIR, MS, (1)H, (13)C{(1)H} and (31)P{(1)H} NMR spectral data. The solid-state structure of cis -5b was examined by single-crystal X-ray diffraction techniques. In addition, the compounds were tested in HeLa cancer cell lines using MTT assay. The 12 phosphazene derivatives were screened for antimicrobial activity, and 3c was very effective against S. aureus even at 4.88 µM concentration, taking into account the MIC values. Besides, interactions between the phosphazenes and pBR322 plasmid DNA were also investigated.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25491284     DOI: 10.1007/s00775-014-1223-5

Source DB:  PubMed          Journal:  J Biol Inorg Chem        ISSN: 0949-8257            Impact factor:   3.358


  14 in total

1.  Phosphorus-nitrogen compounds. 21. Syntheses, structural investigations, biological activities, and DNA interactions of new N/O spirocyclic phosphazene derivatives. The NMR behaviors of chiral phosphazenes with stereogenic centers upon the addition of chiral solvating agents.

Authors:  Muhammet Işiklan; Nuran Asmafiliz; Ezgi Elif Ozalp; Elif Ece Ilter; Zeynel Kiliç; Bünyemin Coşut; Serkan Yeşilot; Adem Kiliç; Asli Oztürk; Tuncer Hökelek; L Yasemin Koç Bilir; Leyla Açik; Emel Akyüz
Journal:  Inorg Chem       Date:  2010-08-02       Impact factor: 5.165

2.  Revisiting the electronic structure of phosphazenes.

Authors:  Adrian B Chaplin; John A Harrison; Paul J Dyson
Journal:  Inorg Chem       Date:  2005-11-14       Impact factor: 5.165

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives.

Authors:  Mariola Siwy; Danuta Sek; Bozena Kaczmarczyk; Iwona Jaroszewicz; Anna Nasulewicz; Marzena Pelczyñska; Dmitry Nevozhay; Adam Opolski
Journal:  J Med Chem       Date:  2006-01-26       Impact factor: 7.446

5.  Diastereoisomeric singly bridged cyclophosphazene-macrocyclic compounds.

Authors:  Iwona Porwolik-Czomperlik; Krystyna Brandt; T Andrew Clayton; David B Davies; Robert J Eaton; Robert A Shaw
Journal:  Inorg Chem       Date:  2002-09-23       Impact factor: 5.165

6.  Low temperature formation of hydroxyapatite-poly(alkyl oxybenzoate)phosphazene composites for biomedical applications.

Authors:  Y E Greish; J D Bender; S Lakshmi; P W Brown; H R Allcock; C T Laurencin
Journal:  Biomaterials       Date:  2005-01       Impact factor: 12.479

7.  Anomalous NMR behavior of meso compounds with remote stereogenic centers on addition of chiral shift reagent or chiral solvating agent.

Authors:  Serap Beşli; Simon J Coles; David B Davies; Robert J Eaton; Michael B Hursthouse; Adem Kiliç; Robert A Shaw; Gönül Yenilmez Ciftçi; Serkan Yeşilot
Journal:  J Am Chem Soc       Date:  2003-04-23       Impact factor: 15.419

8.  Conformationally rigid chelate rings in metal complexes of pyridyloxy-substituted 2,2'-dioxybiphenyl-cyclotetra- and cyclotriphosphazene platforms.

Authors:  Eric W Ainscough; Andrew M Brodie; Andreas Derwahl; Steve Kirk; Carl A Otter
Journal:  Inorg Chem       Date:  2007-10-20       Impact factor: 5.165

9.  New liquid crystalline materials based on two generations of dendronised cyclophosphazenes.

Authors:  Josefina Jiménez; Antonio Laguna; Elena Gascón; José Antonio Sanz; José Luis Serrano; Joaquín Barberá; Luis Oriol
Journal:  Chemistry       Date:  2012-11-07       Impact factor: 5.236

10.  Cellular accumulation and DNA interaction studies of cytotoxic trans-platinum anticancer compounds.

Authors:  Caroline Bartel; Anna K Bytzek; Yulia Yu Scaffidi-Domianello; Gerlinde Grabmann; Michael A Jakupec; Christian G Hartinger; Markus Galanski; Bernhard K Keppler
Journal:  J Biol Inorg Chem       Date:  2012-01-07       Impact factor: 3.862

View more
  3 in total

1.  Phosphorus-nitrogen compounds: part 53-synthesis, characterization, cytotoxic and antimicrobial activity, DNA interaction and molecular docking studies of new mono- and dispirocyclotriphosphazenes with pendant arm(s).

Authors:  Özlem İşcan; Reşit Cemaloğlu; Nuran Asmafiliz; Celal Tuğrul Zeyrek; Zeynel Kılıç; Leyla Açık; Betül Aydın; Mustafa Türk; Tuncer Hökelek
Journal:  Mol Divers       Date:  2021-05-14       Impact factor: 2.943

2.  Phosphorus-nitrogen compounds- (Part 50): correlations between structural parameters for cylophosphazene derivatives containing ferrocenyl pendant arm(s).

Authors:  Nuran Asmafİlİz; Gamze Elmas; Aytuğ OkumuŞ; Selen Bİlge KoÇak; Zeynel KiliÇ
Journal:  Turk J Chem       Date:  2020-06-01       Impact factor: 1.239

3.  Phosphorus-nitrogen compounds (Part 51): the relationship between spectroscopic and crystallographic data of mono- and di- spiro cyclophosphazene derivatives with 4-fluoro/nitrophenylmethyl pendant arm/arms.

Authors:  Aytuğ OkumuŞ; Gamze Elmas; Nuran Asmafİlİz; Selen Bİlge KoÇak; Zeynel KiliÇ
Journal:  Turk J Chem       Date:  2020-06-01       Impact factor: 1.239

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.